RYH

Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $160.30
Change $0.68 | 0.43%
As Of 2/24/17

Investment Objective

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500® Equal Weight Index Health Care.


Net Asset Value

as of 2/24/17
NAV  $160.30
Change $0.68 | 0.43%


Summary


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
Net Expense Ratio 0.40%
IOPV Ticker RYH.IV
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Funds Distributors, LLC.


Profile

as of 2/24/17
Volume 11,204
Last Sale Price $160.21
52-Week Range $161.10 / $139.80
Shares Outstanding 3,150,000
Total Net Assets $504,955,743.32

Overall Morningstar RatingTM *

as of 12/31/16

Among Health Funds

The Fund was rated, based on its risk-adjusted returns, 5 stars for 3 years, 4 stars for 5 years, 4 stars for 10 years, and 4 stars Overall out of 125, 118, 95, and 125 Health funds, respectively.

Market Close

as of 2/24/17
Close  $160.21
Change $0.63 | 0.39%
High | Low $160.25 | $159.21
Bid/Ask Midpoint  $160.27
Premium / Discount  -0.02%


Historical Bid/Ask Midpoint to NAV

as of 2/24/17
  Days % of Total Days
Premium 1102 42.47%
Discount 1249 48.13%
Equal to NAV 244 9.40%
Total 2595 100.00%


Characteristics

as of 2/24/17
Number of Stocks 61
Return on Equity (quarterly 12/30/16) 21.35%
Price to Earning (P/E) 22.33
Price to Book (P/B) 3.08
Dividend Amount $0.17
Ex-Dividend Date N/A


Risk

as of 1/31/17
Standard Deviation Sharpe Ratio Beta R-Squared
13.31 0.80 1.00 99.90

Definitions

Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
R-Squared
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.
Return on Equity Measures a company’s profitability by demonstrating how much profit a company generates with money invested by shareholders. It is calculated by dividing a company’s 12 month net income by shareholder equity and is expressed as a percentage.
Price to Earns (P/E) The weighted average of each individual stock’s P/E ratio. The P/E ratio of a stock is calculated by dividing the current price of the stock by its trailing 12 month’s earnings per share.
Price to Book (P/B) The market price of a stock divided by the book value per share.

NAV is the price per share at which each Fund issues and redeems shares. The net asset value per share for each Fund is determined once daily as of the close of the listing exchange, usually 4:00 p.m. Eastern time, each day the listing exchange is open for trading. NAV per share is determined by dividing the value of the Fund’s portfolio securities, cash and other assets (including accrued interest), less all liabilities (including accrued expenses), by the total number of shares outstanding.

The closing price is the price of the last reported trade on any exchange on which the Fund trades before the market closes, usually at 4 pm Eastern time.

The bid/ask midpoint is the midpoint of the highest bid and lowest offer on the listing exchange at the time that the NAV is calculated, usually 4 pm Eastern time.

The premium/discount is the amount the Fund is trading higher (“premium”) or lower (“discount”) to its NAV, expressed as a percentage of its bid/ask midpoint to its NAV. A positive number indicates it’s trading at premium and a negative number indicates it’s trading at a discount.

Overview

as of 2/24/2017
Total Assets $504,955,743
Number of Stocks 61
Percent Stock 99.84%
Percent Cash / Other 0.16%

Sectors / Industries

as of 2/24/17

Holdings

as of 2/24/17

Security Name Ticker Shares
Held
Market
Value
% of Net Assets Sector / Industry
ILLUMINA INC ILMN 62,278 $9,964,480.00 1.97% Life Sciences Tools & Services
ALLERGAN PLC AGN 39,911 $9,792,962.07 1.94% Pharmaceuticals
IDEXX LABORATORIES INC IDXX 67,442 $9,648,252.52 1.91% Health Care Equipment & Supplies
CENTENE CORP CNC 135,087 $9,538,493.07 1.89% Health Care Providers & Services
ELI LILLY & COMPANY LLY 113,085 $9,371,353.95 1.86% Pharmaceuticals
AMGEN INC. AMGN 53,489 $9,337,039.84 1.85% Biotechnology
BOSTON SCIENTIFIC CORP BSX 368,715 $9,136,757.70 1.81% Health Care Equipment & Supplies
HCA HOLDINGS INC HCA 104,748 $9,120,408.36 1.81% Health Care Providers & Services
INTUITIVE SURGICAL, INC. ISRG 12,269 $9,040,535.34 1.79% Health Care Equipment & Supplies
Cooper Cos Inc/The COO 44,968 $8,981,008.96 1.78% Health Care Equipment & Supplies
AMERISOURCEBERGEN CORP ABC 97,248 $8,962,375.68 1.77% Health Care Providers & Services
ABBOTT LABORATORIES ABT 195,740 $8,941,403.20 1.77% Health Care Equipment & Supplies
MYLAN NV MYL 210,160 $8,860,345.60 1.75% Pharmaceuticals
CERNER CORPORATION CERN 158,532 $8,815,964.52 1.75% Health Care Technology
HENRY SCHEIN, INC. HSIC 50,416 $8,748,688.48 1.73% Health Care Providers & Services
C.R. BARD, INC. BCR 35,415 $8,683,049.70 1.72% Health Care Equipment & Supplies
METTLER-TOLEDO INTERNATIO MTD 18,193 $8,650,043.78 1.71% Life Sciences Tools & Services
BAXTER INTERNATIONAL BAX 171,120 $8,639,848.80 1.71% Health Care Equipment & Supplies
CARDINAL HEALTH, INC. CAH 105,051 $8,628,889.14 1.71% Health Care Providers & Services
UNIVERSAL HEALTH SERVICES UHS 68,463 $8,624,968.74 1.71% Health Care Providers & Services
ANTHEM INC. ANTM 52,596 $8,616,802.68 1.71% Health Care Providers & Services
VERTEX PHARMACEUTICALS VRTX 100,075 $8,613,455.25 1.71% Biotechnology
WATERS CORPORATION WAT 54,996 $8,601,374.40 1.70% Life Sciences Tools & Services
PATTERSON COS INC PDCO 189,923 $8,588,318.06 1.70% Health Care Providers & Services
LABORATORY CORP OF AMERIC LH 60,041 $8,579,258.49 1.70% Health Care Providers & Services
AGILENT TECHNOLOGIES, INC A 165,723 $8,574,508.02 1.70% Life Sciences Tools & Services
ZIMMER BIOMET HOLDINGS IN ZBH 72,921 $8,525,923.32 1.69% Health Care Equipment & Supplies
STRYKER CORP SYK 65,861 $8,513,851.47 1.69% Health Care Equipment & Supplies
MEDTRONIC PLC MDT 104,606 $8,476,224.18 1.68% Health Care Equipment & Supplies
DANAHER CORPORATION DHR 98,245 $8,456,929.60 1.67% Health Care Equipment & Supplies
BECTON DICKINSON & CO BDX 46,080 $8,451,993.60 1.67% Health Care Equipment & Supplies
THERMO FISHER SCIENTIFIC TMO 52,767 $8,388,897.66 1.66% Life Sciences Tools & Services
JOHNSON & JOHNSON JNJ 68,347 $8,388,227.31 1.66% Pharmaceuticals
CIGNA CORPORATION CI 56,919 $8,369,369.76 1.66% Health Care Providers & Services
PFIZER INC PFE 242,050 $8,292,633.00 1.64% Pharmaceuticals
MERCK & COMPANY, INC. MRK 125,312 $8,290,641.92 1.64% Pharmaceuticals
BIOGEN IDEC, INC. BIIB 28,886 $8,236,265.18 1.63% Biotechnology
QUEST DIAGNOSTICS, INC. DGX 84,188 $8,192,334.28 1.62% Health Care Providers & Services
DENTSPLY SIRONA, NC. XRAY 130,004 $8,162,951.16 1.62% Health Care Equipment & Supplies
VARIAN MEDICAL SYSTEMS IN VAR 95,909 $8,125,410.48 1.61% Health Care Equipment & Supplies
EDWARDS LIFESCIENCES CORP EW 84,906 $8,045,692.56 1.59% Health Care Equipment & Supplies
HOLOGIC, INC. HOLX 196,641 $8,026,885.62 1.59% Health Care Equipment & Supplies
CELGENE CORPORATION CELG 67,619 $7,994,594.37 1.58% Biotechnology
ZOETIS INC ZTS 147,871 $7,967,289.48 1.58% Pharmaceuticals
DAVITA, INC DVA 115,399 $7,967,146.96 1.58% Health Care Providers & Services
MCKESSON CORPORATION MCK 52,464 $7,914,194.40 1.57% Health Care Providers & Services
PERKINELMER PKI 143,259 $7,884,975.36 1.56% Life Sciences Tools & Services
PERRIGO COMPANY PRGO 93,005 $7,852,412.15 1.56% Pharmaceuticals
HUMANA, INC. HUM 37,744 $7,823,576.32 1.55% Health Care Providers & Services
UNITEDHEALTH GROUP INC. UNH 47,918 $7,813,509.08 1.55% Health Care Providers & Services
MALLINCKRODT PLC MNK 145,872 $7,786,647.36 1.54% Pharmaceuticals
ABBVIE INC ABBV 124,683 $7,741,567.47 1.53% Biotechnology
AETNA INC AET 59,521 $7,676,423.37 1.52% Health Care Providers & Services
ALEXION PHARMACEUTICALS I ALXN 58,096 $7,641,947.84 1.51% Biotechnology
ENVISION HEALTHCARE CORP EVHC 107,043 $7,641,799.77 1.51% Health Care Providers & Services
BRISTOL MYERS SQUIBB CO BMY 134,520 $7,592,308.80 1.50% Pharmaceuticals
EXPRESS SCRIPTS HLDGS ESRX 105,861 $7,574,354.55 1.50% Health Care Providers & Services
REGENERON PHARMACEUTICALS REGN 20,579 $7,429,224.79 1.47% Biotechnology
GILEAD SCIENCES, INC. GILD 105,544 $7,381,747.36 1.46% Biotechnology
ENDO INETERNATIONAL PLC ENDP 490,600 $6,451,390.00 1.28% Pharmaceuticals
FEDERATED US TREAS CASH RESERVE INSTITUTIONAL 634,449 $634,448.87 0.13% na
BIOVERATIV INC BIVV 1 $25.48 0.00% Biotechnology

Disclosure

*The Morningstar Rating for funds, or "star rating", is calculated for managed products with at least a three-year history and does not include the effect of sales charges. Exchange-traded funds and open-end mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics.

© 2016 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

Standard & Poor's® and S&P® are registered trademarks of Standard & Poor's Financial Services LLC, a subsidiary of McGraw Hill Financial, Inc., and have been licensed for use by Guggenheim Investments and its affiliates. Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC. S&P Dow Jones Indices LLC (together with its affiliates, "S&P") does not make investment recommendations, and S&P does not sponsor, endorse, sell or promote the product. S&P makes no representation or warranty regarding the advisability of investing in the product. Past performance of an index is not a guarantee of future results.
 

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.

Guggenheim

Subscribe to Perspectives



©2017 Guggenheim Investments. All Rights Reserved.

Research our firm with FINRA Broker Check.

• Not FDIC Insured • No Bank Guarantee • May Lose Value